TrustPartners ha recently published on Slideshare a brief presentation about the entry strategies in the Brazilian pharmaceutical market, with analysis of the local legislation and description of the market access strategies for a foregin pharmaceutical company.

Brazilian pharmaceutical market ha been characterized, in the past years, to a steady grow in terms of revenues and volumes, supported by the regulatory activity realized (still in progress) by its national Public institutions and aimed to realize a more transparent, efficient and competitive market.

Thanks to its high perspective growth rate and population, Brazil is considered one of the main national market worldwide: its economical and infrastructural market characteristics (closer to the western-capitalistic Countries), makes it surely the most appealing among the emerging pharmaceutical markets.

TrustPartners has a deep know-how and experience in the pharmaceutical industry, supporting several international pharmaceutical companies. In the last years, in line with the italian pharmaceutical success in Brazil, it has launched several relationships with the main public institutions and local Brazilian stakeholdersm, supported by a local consulting company focused on the pharmaceutical market access.

TrustPartners is able to support any interested pharmaceutical company during the start-up activities in Brazil: from the license granting process, to the partner scouting, the start-up strategies definition and the project management activities.